News from paragon bioteck, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 18, 2016, 09:00 ET Hasenin Al-khersan Named 2016 Koch Kellan Scholar

 Paragon BioTeck, Inc., announced today that Hasenin Al-khersan has been named its 2016 Koch Kellan Scholar. Paragon Gives, a Paragon BioTeck...


Mar 29, 2016, 08:55 ET Paragon BioTeck Receives EN ISO 13485:2012 Certification

 Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, announced today that it has received EN ISO 13485:2012...


Jan 07, 2016, 19:17 ET Paragon BioTeck to Attend 34th Annual J.P. Morgan Healthcare Conference

Paragon BioTeck, Inc., a privately held pharmaceutical and medical device company, will sponsor a special reception during the J.P. Morgan 2016...


Nov 17, 2014, 09:00 ET Paragon BioTeck Receives CE Mark Approval on Comfortear® Lacrisolve™ Absorbable Punctum Plug

 Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...


Oct 16, 2014, 10:00 ET Paragon BioTeck, Inc. Announces Corporate Citizenship Initiative, 'Paragon Gives'

 Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...


Oct 15, 2014, 15:36 ET Paragon BioTeck to Exhibit at American Academy of Ophthalmology Annual Meeting in Chicago

 Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...


Jun 25, 2014, 16:29 ET Paragon BioTeck, Inc. Receives FDA Clearance for Comfortear Lacrisolve Absorbable Punctum Plug

 Paragon BioTeck, Inc., a privately held biopharmaceutical and medical device company specializing in the development of ophthalmic...


Jun 04, 2014, 12:28 ET Paragon BioTeck announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available

Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...


Apr 09, 2014, 08:00 ET Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent Readily Available

 Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies,...


Nov 08, 2013, 18:50 ET Paragon Puts Ilast® Center Stage

 Leading biopharmaceutical company Paragon BioTeck, Inc. announced today that it plans to launch its new line of products, known as...


Oct 09, 2013, 13:59 ET Paragon BioTeck Signs Exclusive Distribution Agreement with Horus Pharma for Ilast®

Paragon BioTeck, Inc. today announced that it has signed a distribution agreement with Horus Pharma for rights to supply the Ilast® range of...


Apr 19, 2013, 20:11 ET Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine

 Bausch + Lomb, the global eye health company and Paragon BioTeck, Inc. today announced that the companies have entered into a license...